Juan Carlos Gomez, MD, MBA, is the Chief Medical Officer of Shionogi, a pharmaceutical company headquartered in Osaka, Japan, that is focused on developing innovative treatments for infectious diseases and pain-CNS disorders.

Before joining Shionogi in 2019, Dr. Gomez had a long career in pharmaceutical drug development, having held senior leadership positions at Eli Lilly and Roche, mainly in neuroscience and neurodevelopmental disorders. He has a doctorate from the Universidad Complutense de Madrid and a master’s from IESE Universidad de Navarra. He is a certified specialist in psychiatry from the Hospital Clínico San Carlos in Madrid.